Daniel A. Bochar

2.8k total citations
28 papers, 2.1k citations indexed

About

Daniel A. Bochar is a scholar working on Molecular Biology, Pharmacology and Genetics. According to data from OpenAlex, Daniel A. Bochar has authored 28 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 4 papers in Pharmacology and 4 papers in Genetics. Recurrent topics in Daniel A. Bochar's work include Plant biochemistry and biosynthesis (7 papers), Genomics and Chromatin Dynamics (7 papers) and Cancer-related gene regulation (4 papers). Daniel A. Bochar is often cited by papers focused on Plant biochemistry and biosynthesis (7 papers), Genomics and Chromatin Dynamics (7 papers) and Cancer-related gene regulation (4 papers). Daniel A. Bochar collaborates with scholars based in United States, Netherlands and Canada. Daniel A. Bochar's co-authors include Ramin Shiekhattar, Mohamed‐Ali Hakimi, William S. Lane, Weidong Wang, Victor W. Rodwell, Alexander Kinev, Cynthia V. Stauffacher, Fatah Kashanchi, Yutong Xue and Lai Wang and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Daniel A. Bochar

28 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel A. Bochar United States 19 1.9k 491 188 160 138 28 2.1k
Xiaobei Zhao United States 23 2.1k 1.1× 282 0.6× 210 1.1× 174 1.1× 405 2.9× 43 2.8k
Kwanghee Baek South Korea 26 1.4k 0.7× 281 0.6× 138 0.7× 126 0.8× 335 2.4× 80 2.0k
Anthony Rossomando United States 24 2.2k 1.2× 205 0.4× 332 1.8× 154 1.0× 142 1.0× 39 2.9k
Hualin Simon Xi United States 25 2.1k 1.1× 488 1.0× 142 0.8× 689 4.3× 267 1.9× 35 2.7k
Laura R. Pearce United Kingdom 8 1.6k 0.9× 167 0.3× 188 1.0× 81 0.5× 137 1.0× 9 2.1k
Débora Bonenfant Switzerland 15 2.1k 1.1× 151 0.3× 291 1.5× 166 1.0× 164 1.2× 19 2.6k
Jorrit M. Enserink Norway 23 2.0k 1.1× 172 0.4× 379 2.0× 132 0.8× 183 1.3× 57 2.6k
Shunji Ohsako Japan 19 1.3k 0.7× 179 0.4× 113 0.6× 134 0.8× 116 0.8× 44 1.7k
Alexias Safi United States 20 2.2k 1.2× 590 1.2× 210 1.1× 148 0.9× 289 2.1× 36 2.6k
Chenbo Zeng United States 29 1.8k 1.0× 103 0.2× 287 1.5× 69 0.4× 129 0.9× 40 2.4k

Countries citing papers authored by Daniel A. Bochar

Since Specialization
Citations

This map shows the geographic impact of Daniel A. Bochar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel A. Bochar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel A. Bochar more than expected).

Fields of papers citing papers by Daniel A. Bochar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel A. Bochar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel A. Bochar. The network helps show where Daniel A. Bochar may publish in the future.

Co-authorship network of co-authors of Daniel A. Bochar

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel A. Bochar. A scholar is included among the top collaborators of Daniel A. Bochar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel A. Bochar. Daniel A. Bochar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Yujin, Jesse W. Wotring, Sahil Arora, et al.. (2023). TMPRSS2 Inhibitor Discovery Facilitated through an In Silico and Biochemical Screening Platform. ACS Medicinal Chemistry Letters. 14(6). 860–866. 10 indexed citations
2.
Johnson, Taylor K., et al.. (2021). Synergy and Antagonism between Allosteric and Active‐Site Inhibitors of Abl Tyrosine Kinase. Angewandte Chemie International Edition. 60(37). 20196–20199. 15 indexed citations
3.
Johnson, Taylor K., et al.. (2021). Synergy and Antagonism between Allosteric and Active‐Site Inhibitors of Abl Tyrosine Kinase. Angewandte Chemie. 133(37). 20358–20361. 1 indexed citations
4.
Liu, Mengyu, Thomas S. Dexheimer, Dexin Sui, et al.. (2020). Hyperphosphorylated tau aggregation and cytotoxicity modulators screen identified prescription drugs linked to Alzheimer's disease and cognitive functions. Scientific Reports. 10(1). 16551–16551. 40 indexed citations
5.
Liu, Mengyu, Dexin Sui, Thomas S. Dexheimer, et al.. (2020). Hyperphosphorylation Renders Tau Prone to Aggregate and to Cause Cell Death. Molecular Neurobiology. 57(11). 4704–4719. 46 indexed citations
6.
Yates, Joel A., Tushar Menon, Brandi Thompson, & Daniel A. Bochar. (2010). Regulation of HOXA2 gene expression by the ATP‐dependent chromatin remodeling enzyme CHD8. FEBS Letters. 584(4). 689–693. 34 indexed citations
7.
Aminoff, David, Daniel A. Bochar, Amelia A. Fuller, et al.. (2009). Research into selective biomarkers of erythrocyte exposure to organophosphorus compounds. Analytical Biochemistry. 392(2). 155–161. 3 indexed citations
8.
Patel, Paresh D., et al.. (2007). Regulation of Tryptophan Hydroxylase-2 Gene Expression by a Bipartite RE-1 Silencer of Transcription/Neuron restrictive Silencing Factor (REST/NRSF) Binding Motif. Journal of Biological Chemistry. 282(37). 26717–26724. 38 indexed citations
9.
Adams, Melissa M., Bin Wang, Zhenfang Xia, et al.. (2005). 53BP1 Oligomerization is Independent of its Methylation by PRMT1. Cell Cycle. 4(12). 1854–1861. 66 indexed citations
10.
Hakimi, Mohamed‐Ali, Daniel A. Bochar, John A. Schmiesing, et al.. (2002). A chromatin remodelling complex that loads cohesin onto human chromosomes. Nature. 418(6901). 994–998. 225 indexed citations
11.
Marmorstein, Lihua Y., Alexander Kinev, Gordon K. Chan, et al.. (2001). A Human BRCA2 Complex Containing a Structural DNA Binding Component Influences Cell Cycle Progression. Cell. 104(2). 247–257. 114 indexed citations
12.
Bochar, Daniel A., Lai Wang, Alexander Kinev, et al.. (2000). BRCA1 Is Associated with a Human SWI/SNF-Related Complex. Cell. 102(2). 257–265. 441 indexed citations
13.
Rodwell, Victor W., Michael J. Beach, Kenneth M. Bischoff, et al.. (2000). 3-Hydroxy-3-methylglutaryl-CoA Reductase. Methods in enzymology on CD-ROM/Methods in enzymology. 324. 259–280. 29 indexed citations
14.
Bochar, Daniel A., Julie Savard, Weidong Wang, et al.. (2000). A family of chromatin remodeling factors related to Williams syndrome transcription factor. Proceedings of the National Academy of Sciences. 97(3). 1038–1043. 125 indexed citations
15.
Bochar, Daniel A., Cynthia V. Stauffacher, & Victor W. Rodwell. (1999). Sequence Comparisons Reveal Two Classes of 3-Hydroxy-3-methylglutaryl Coenzyme A Reductase. Molecular Genetics and Metabolism. 66(2). 122–127. 87 indexed citations
16.
Bochar, Daniel A., et al.. (1999). Inhibition of Transcription by the Trimeric Cyclin-dependent Kinase 7 Complex. Journal of Biological Chemistry. 274(19). 13162–13166. 9 indexed citations
17.
Bochar, Daniel A., et al.. (1999). Expression and Characterization of the HMG-CoA Reductase of the Thermophilic Archaeon Sulfolobus solfataricus. Protein Expression and Purification. 17(3). 435–442. 8 indexed citations
18.
Tabernero, Lydia, Daniel A. Bochar, Victor W. Rodwell, & Cynthia V. Stauffacher. (1999). Substrate-induced closure of the flap domain in the ternary complex structures provides insights into the mechanism of catalysis by 3-hydroxy-3-methylglutaryl–CoA reductase. Proceedings of the National Academy of Sciences. 96(13). 7167–7171. 71 indexed citations
19.
20.
Kirby, John R., et al.. (1995). Chemotactic methylation and behavior in Bacillus subtilis: role of two unique proteins, CheC and CheD. Biochemistry. 34(11). 3823–3831. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiaobei Zhao Breakdown of academic impact, for papers by Kwanghee Baek Breakdown of academic impact, for papers by Anthony Rossomando Breakdown of academic impact, for papers by Hualin Simon Xi Breakdown of academic impact, for papers by Laura R. Pearce Breakdown of academic impact, for papers by Débora Bonenfant Breakdown of academic impact, for papers by Jorrit M. Enserink Breakdown of academic impact, for papers by Shunji Ohsako Breakdown of academic impact, for papers by Alexias Safi Breakdown of academic impact, for papers by Chenbo Zeng
Rankless by CCL
2026